Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Formative Phase)

Enrolling by invitationOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

November 30, 2025

Conditions
HIV Pre-exposure ProphylaxisHEPATITIS C (HCV)
Trial Locations (1)

30628

MedLink Georgia, Colbert

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Georgia

OTHER